ExodusPoint Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
ExodusPoint Capital Management's MDGL Position: Q3 2026 in Review
ExodusPoint Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2026, closing a stake of 3,384 shares — an estimated $1.82M sold.
ExodusPoint Capital Management first reported a position in MDGL in Q3 2020 and held it in 9 quarters. The position peaked at $2.92M in Q1 2026. 440 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- ExodusPoint Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 3,384 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $1.82M.
- ExodusPoint Capital Management first reported a position in Madrigal Pharmaceuticals in Q3 2020 and held it in 9 quarters.
- ExodusPoint Capital Management's Madrigal Pharmaceuticals position peaked at $2.92M in Q1 2026.
- 440 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.